NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.61
-0.52 (-6.40%)
Apr 28, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $87.56 million as of April 29, 2026. Its market cap has increased by 577.87% in one year.
Market Cap
87.56M
Enterprise Value
83.02M
1-Year Change
577.87%
Ranking
Category
Stock Price
$7.61
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $87.56M, an increase of 376.58%. That is a compound annual growth rate of 77.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 93.54M | 93.41% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 94.23M |
| eXoZymes | 87.55M |
| Rani Therapeutics Holdings | 86.64M |
| PolyPid | 84.54M |
| Pelthos Therapeutics | 83.79M |
| Q32 Bio | 83.68M |
| Sangamo Therapeutics | 83.27M |
| OKYO Pharma | 82.92M |